Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Water-Related Injuries |
|
|
Clinical Trial: Methylphenidate in the Treatment of Cocaine Dependent Patients with Adult Attention Deficit Hyperactivity Disorder - 5
This study is no longer recruiting patients.
Purpose
The purpose of this study is the use of Methylphenidate in the treatment of cocaine dependence and Attention Deficit Hyperactivity Disorder (ADHD) comorbidity.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders Substance-Related Disorders | Drug: Methylphenidate | Phase II |
MedlinePlus related topics: Cocaine Abuse; Drug Abuse; Prescription Drug Abuse
Study Type: Interventional
Study Design: Treatment, Double-Blind, Placebo Control
Official Title: Methyphendidate in the Treatment of Cocaine Dependent Patients with Adult ADHD
Study start: June 1997; Study completion: December 1999
The objective of this study is to determine the safety and efficacy of methylphenidate in a population of patients who are cocaine dependent and suffer from attention deficit hyperactivity disorder.
Eligibility
Ages Eligible for Study: 21 Years - 50 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
Cocaine-dependent. Meets the DSM-IV criteria for ADHD. Actively using cocaine within the past 30 days of screening.
Exclusion Criteria:
Symptoms of AIDS. Significant medical disorder. DSM-IV criteria for any substance other than cocaine, alcohol, nicotine, marijuana, caffeine. Requires detoxification from ETOH or benzos. History of seizures.
Location Information
New York
New York MDRU, New York, New York, 10010, United States
John Rotrosen, M.D., Principal Investigator, New York MDRU
More Information
Record last reviewed: June 1997
Last Updated: December 3, 2004
Record first received: April 18, 2001
ClinicalTrials.gov Identifier: NCT00015223
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
